Acreage Holdings Future Growth
Future criteria checks 2/6
Acreage Holdings is forecast to grow earnings and revenue by 148.4% and 26.4% per annum respectively.
Key information
148.4%
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 19.4% |
Revenue growth rate | 26.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 31 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 282 | -3 | N/A | 2 | 1 |
12/31/2024 | 212 | -7 | N/A | -4 | 1 |
6/30/2024 | 194 | -87 | -32 | -13 | N/A |
3/31/2024 | 213 | -82 | -31 | -11 | N/A |
12/31/2023 | 223 | -69 | -34 | -15 | N/A |
9/30/2023 | 228 | -133 | -49 | -38 | N/A |
6/30/2023 | 233 | -148 | -51 | -42 | N/A |
3/31/2023 | 236 | -142 | -66 | -53 | N/A |
12/31/2022 | 237 | -140 | -69 | -50 | N/A |
9/30/2022 | 238 | -85 | -72 | -53 | N/A |
6/30/2022 | 224 | -75 | -73 | -43 | N/A |
3/31/2022 | 207 | -68 | -80 | -44 | N/A |
12/31/2021 | 189 | -63 | -74 | -41 | N/A |
9/30/2021 | 162 | -60 | -77 | -42 | N/A |
6/30/2021 | 146 | -88 | -73 | -49 | N/A |
3/31/2021 | 129 | -122 | -57 | -44 | N/A |
12/31/2020 | 115 | -287 | -83 | -68 | N/A |
9/30/2020 | 104 | -300 | -82 | -59 | N/A |
6/30/2020 | 95 | -298 | -110 | -73 | N/A |
3/31/2020 | 85 | -299 | -131 | -83 | N/A |
12/31/2019 | 74 | -150 | -176 | -71 | N/A |
9/30/2019 | 63 | -125 | -171 | -65 | N/A |
6/30/2019 | 47 | -99 | -159 | -58 | N/A |
3/31/2019 | 32 | -47 | -132 | -40 | N/A |
12/31/2018 | 21 | -27 | -64 | -36 | N/A |
9/30/2018 | 13 | -8 | -46 | -29 | N/A |
6/30/2018 | 9 | 3 | -28 | -19 | N/A |
3/31/2018 | 8 | -11 | N/A | -14 | N/A |
12/31/2017 | 8 | -9 | N/A | -6 | N/A |
12/31/2016 | 4 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0VZ1 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0VZ1 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0VZ1 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0VZ1's revenue (26.4% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 0VZ1's revenue (26.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0VZ1's Return on Equity is forecast to be high in 3 years time